<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>0</Volume><Issue>4</Issue><PubDate PubStatus="epublish"><Year>2015</Year><Month>07</Month><Day>22</Day></PubDate></Journal><title locale="en_US">The Effect of Multi mineral‑Vitamin D Supplementation on Pregnancy Outcomes in Pregnant Women at Risk for Pre‑eclampsia</title><FirstPage>1555</FirstPage><LastPage>1555</LastPage><Language>EN</Language><AuthorList><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2015</Year><Month>07</Month><Day>21</Day></PubDate></History><abstract locale="en_US">&lt;strong&gt;Background:&lt;/strong&gt; The objective of this study was to determine the favorable effects of multi mineral‑Vitamin D supplementation on pregnancy outcomes among women at risk for pre‑eclampsia.&lt;br /&gt;&lt;strong&gt;Methods:&lt;/strong&gt; This randomized double‑blind controlled clinical trial was conducted among 46 women at risk for pre‑eclampsia at 27 weeks&amp;rsquo; gestation with positive roll‑over test. Pregnant women&lt;br /&gt;were randomly assigned to receive either the multi mineral‑Vitamin D supplements (n = 23) or the placebo (n =23) for 9‑week. Multi mineral‑Vitamin D supplements were containing 800 mg calcium, 200 mg magnesium, 8 mg zinc, and 400 IU Vitamin D3. Fasting blood samples were taken at baseline and after 9‑week intervention to measure related factors. Newborn&amp;rsquo;s outcomes were determined.&lt;br /&gt;&lt;strong&gt;Results:&lt;/strong&gt; Although no significant difference was seen in newborn&amp;rsquo;s weight and head circumference between the two groups, mean newborns&amp;rsquo; length (51.3 &amp;plusmn; 1.7 vs. 50.3 &amp;plusmn; 1.2 cm, P = 0.03) was significantly higher in multi mineral‑Vitamin D group than that in the placebo group. Compared to the placebo, consumption of multi mineral‑Vitamin D supplements resulted in increased levels of serum calcium (+0.19 vs. &amp;minus;0.08 mg/dL, P = 0.03), magnesium (+0.15 vs. &amp;minus;0.08 mg/dL, P = 0.03),&lt;br /&gt;zinc (+8.25 vs. &amp;minus;21.38 mg/dL, P = 0.001) and Vitamin D (+3.79 vs. &amp;minus;1.37 ng/ml, P = 0.01). In addition, taking multi mineral‑Vitamin D supplements favorably influenced systolic blood pressure (SBP) (&amp;minus;1.08 vs. 6.08 mmHg, P = 0.001) and diastolic blood pressure (DBP) (&amp;minus;0.44 vs. 3.05 mmHg, P = 0.02).&lt;br /&gt;&lt;strong&gt;Conclusions:&lt;/strong&gt; Multi mineral‑Vitamin D supplementation for 9‑week in pregnant women at risk for pre‑eclampsia resulted in increased newborn&amp;rsquo;s length, increased circulating levels of maternal serum calcium, magnesium, zinc and Vitamin D, and led to decreased maternal SBP and DBP.&lt;br /&gt;&lt;strong&gt;Keywords:&lt;/strong&gt; Multi mineral‑Vitamin D supplementation, pre‑eclampsia, pregnancy outcomes</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/1555</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/1555/1847</pdf_url></Article></Articles>
